Large Bore Vascular Closure Devices Market Size, Share, Growth and Industry Analysis by type ( Passive Closure Devices, Active Closure Devices ) by Application. ( Femoral Arterial, Transradial Arterial) Regional Forecast to 2035

LARGE BORE VASCULAR CLOSURE DEVICES MARKET OVERVIEW

The global large bore vascular closure devices market size was USD 763.84 million in 2026 and is projected to touch USD 1829.41 million by 2035, exhibiting a CAGR of 8.2% during the forecast period.

The growing need for large-bore access in interventional procedures due to the rising incidence of cardiovascular diseases is a significant driver for the increased demand for large-bore vascular closure devices. These devices are critical in the hemostasis needed in recovery after such procedures as transcatheter aortic valve replacement (TAVR), endovascular aneurysm repair (EVAR), and pretty much all high sheath interventions.

Moreover, technological developments that result in closure devices are among innovations that lower complication rates and improve patient outcomes, further boosting market expansion. Preference toward minimally invasive procedures is increasing among patients and healthcare providers alike; hence more demand on any reliable and effective vascular closure device.

Such facilitating healthcare infrastructure development in emerging economies coupled with an increased focus on shorter hospital stays and procedural efficiency will also respond to this market. There is, however, a potential increase in market awareness over time as more benefits of these devices come to light.

• 

  Request a Free sample to learn more about this report.

GLOBAL CRISE IMPACTING LARGE BORE VASCULAR CLOSURE DEVICES MARKET : IMPACT OF COVID-19 PANDEMIC

"Pandemic-Driven Healthcare Shifts Accelerate Demand and Innovation in Vascular Closure Solutions"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic produced a teeming range of effects on the Large Bore Vascular Closure Devices market. As the pandemic wore on, so did the transition period for hospitals setting up their new normal. Resumption of elective procedures was done with much more rigorous safety precautions. Additionally, the greater attention placed on improvement of healthcare infrastructure and preparedness for critical care has indirectly aided market recovery. As the disruption fizzled out, interventional cardiovascular procedures were once again on the rise, in turn consolidating the demand for large-bore closure devices.

At the same time, the pandemic hastened the acceptance of advanced medical technologies and minimally invasive techniques, which favorably for the long term has positively affected the market. The renewed focus on efficiency, patient safety, and reduced hospital stays has kept interest afloat in vascular closure solutions perceived as reliable.

MARKET TREND

"Rising Demand for Faster Hemostasis Drives Shift Toward Active Closure Devices in Complex Procedures"

The prominent trends within the Large Bore Vascular Closure Devices market is the overall increasing trend of favoring active closure devices over passive closure devices. Active closure devices usually perform their function via sutures or clips---that is, through mechanical means. Therefore, they provide rapid and secure control over hemostasis at the same time, this timing becomes extremely important in large bore access procedures such as endovascular surgery or cardiovascular surgery. They mitigate such complications as bleeding and therefore, delay recovery and are thereby chosen over passive devices by caregivers. In active closure devices, precision, efficacy, and versatility to adapt requirement through different procedural demands have further contributed toward their supremacy in the market.

MARKET SEGMENTATION

By Type

Market Segmentation  based on type includes Passive Closure Devices & Active Closure Devices.

• Passive Closure Devices: Passive closure devices utilize the body's healing mechanisms to obtain hemostasis. They include manual compression, mechanical pressure devices, or collagen plugs, all of which are implicated in the formation of clots. Albeit simpler and less expensive, these methods are generally associated with longer recovery times and prolonged immobility following the procedure. The use of passive closure devices has decreased in large bore access procedures, owing to the complications of prolonged bleeding or hematoma.
• Active Closure Devices: Active closure devices rely on mechanical closure techniques such as sutures, clips, or staples to immediately close the arterial puncture site; thus promoting swift and reliable hemostasis that is paramount for any of the high-risk or large bore procedures, e.g., TAVR or EVAR. Active devices reduce time to ambulation, hospital stay, and complications while being the favorite option in today's vascular practice. Their precision and adaptability over procedural variations will further support their growth in the market.

By Application

Market Segmentation  based on application  includes Femoral Arterial Access & Transradial Arterial Access

• Femoral Arterial Access: The most common area of access for using large bore is via the femoral artery, which is large and easily navigable to the central vessels. Thus, after transcatheter aortic valve replacement or endovascular aneurysm repair, large bore vascular closure devices are usually utilized. Puncture sizes are large in these procedures, hence closure must be reliable to minimize the amount of bleeding and hasten healing. Therefore, the demand for an effective closure device is strong and growing for femoral access.
• Transradial Arterial Access: Traditionally this access is applied for smaller bore; now it is developing outwards into more significant interventional complications to which catheters may be attached. It allows for less bleeding and faster recovery. However, the radial artery has been quite small, and therefore, it has some specific closures. Innovations in miniaturization and adaptability for devices are also helping in broadening this segment, but it remains, at the moment, a smaller segment compared to femoral applications.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

"Surge in Minimally Invasive Cardiac Procedures Fuels Demand for Efficient Large Bore Closure Devices"

There are growing numbers of minimally invasive cardiovascular procedures. The valuations show that all patients today undergo increasingly common procedures, such as transcatheter aortic valve replacement (TAVR) or endovascular aneurysms repair (EVAR), as the burden of cardiovascular disease rises for individuals worldwide. Though they usually require large bore vascular access, this has necessitated high efficient and reliable closure devices that will ensure quick hemostasis and rehabilitation of the patient.

"Advancements in Active Closure Device Technology Enhance Procedure Efficiency, Driving Market Growth"

Improvements in modern technologies of active closure devices-suture-based-clip-based systems-have raised their use further to increase operational precision, safety, and ease of application. With decrease in complications and time of the procedures as well as length of hospital stay, this feature makes the medical service provider more attractive and thus promotes market growth.

Restraning Factors

"High Initial Costs of Active Closure Devices Limit Adoption in Budget-Constrained Healthcare Settings"

Advanced technologies employed in active closure devices are costlier than their passive counterparts. This situation may limit their adoption especially in budget-limited areas due to small health facilities adopting cost-effectiveness as the primary consideration. The high initial costs may further influence the low acceptance, although the benefits would be realized in the long term-benefits such as reduced complication rates and shorter hospital stays.

Opprtunity

"Emerging Healthcare Investments in Developing Economies Drive Demand for Advanced Vascular Closure Devices"

Such emerging healthcare infrastructures in developing economies will contribute significantly to the enormous opportunity that will arise in the Large Bore Vascular Closure Devices market. Increased investments in health infrastructure and awareness about the incidence of cardiovascular diseases will create demands for advanced medical technologies. Thus, it presents an ideal opportunity for companies to introduce their cost-effective and high-quality vascular closure devices into these markets, which certainly will broaden the already establishing consumer base.

Challenges

Stringent Regulatory Approval Processes Delay Market Access, Hindering Timely Revenue Potential

The large aperture vascular closure devices market has a major challenge; that being the tortuous and straitjacketed approval processes in several nations worldwide. Approval by health authorities often is slow and costly. Particularly, for new devices with an innovative technology, such a condition may delay market access and hence deprive revenue potential for manufacturers for emerging opportunities on a timely basis.

REGIONAL INSIGHT OF LARGE BORE VASCULAR CLOSURE DEVICES MARKET

• North America

This is where North America-with the United States as the main player-has almost total hegemony over the global Large Bore Vascular Closure Devices market. This region's advanced healthcare infrastructure, high healthcare expenditure, and strong presence of leading medical device manufacturers are the contributing factors. Growing cardiovascular conditions worldwide and increased volume to perform minimally invasive procedures such as TAVR and EVAR have raised public demand for vascular closure device. In addition, the established reimbursement policy in the United States, along with an early adoption of new age technologies, is the reason behind the damages of the growth of this market by region.

• Europe

Large organizations for large-bore vascular closure devices are located within Europe, whose booming demand is associated with the increasingly aging population in the area and rising cardiovascular diseases incidence rates. It includes Germany, the UK, and in France, among other countries, where minimally invasive surgical procedures are giving way to driving demand for closing devices. Increased attention is also being paid to intervention outcomes and reduction of recovery periods; hence, these will also aid growth in the market. Steady growth is expected in the region from the technological changes and supportive regulatory policies promoting innovations.

• Asia

This region is now slowly maturing into one of the most significant emerging markets, with phenomenal improvements in healthcare infrastructures mainly in China, India, and Japan. There is a rising emergence of cardiovascular diseases within this region; consequently, as the medical facilities become updated with the most modern technological level, there comes along a requirement for more advanced Modern Medical Technology, such as large bore vascular closure devices. The systems are eco-sensitive, and some areas lack awareness about the advantages of such devices, which could become roadblocks to growth. However, the market is constantly increasing due to expansion within the healthcare sector and people becoming more aware of cardiovascular awareness.

KEY INDUSTRY PLAYERS

All the mentioned companies have been named because larger bore vascular closure devices are one of the important domains that attract all the major medical device companies across the globe. The other fields that are the fancy of these major players are cardiovascular devices and innovations triggering different vascular closure system technologies. While Abbott Laboratories has its attention on precision and effectiveness in dealing with complications arising during interventional procedures, the devices of choice for such other complex procedures are the AVenmeds, AV sees, and AV hemostatic devices from Medtronic and those from Boston Scientific Vantage, Accord, and Advantage. Terumo Corporation, too, gets quite a bang from the vascular closure devices towards building patient throughput and procedural efficiencies. These companies keep on pouring in and pouring in research and development funds to meet the ever-increasing demand from numerous seekers of advanced yet economical solutions for ever-less-invasive procedures.

List Of Top Large Bore Vascular Closure Devices Companies

• Abbott Vascular (United States)
• Abbott (United States)
• Vascular Solutions (United States)
• Essential Medical (United States)
• InSeal Medical (Israel)
• Medeon Biodesign (United States)
• Morris Innovative (United States)
• Transluminal Technologies (India)
• Vasorum (United Kingdom)
• Cardinal Health (United States)

KEY INDUSTRY DEVELOPMENT

In July 2024, FDA clearance for MYNX CONTROL VENOUS vascular closure device was granted to Cordis, enabling the development of an extravascular closure solution range. The device is suitable for access sizes of 6F-12F, allowing for predictable deployment and straightforward handling. This approval adds to Cordis' offerings in the vascular closure market, thus increasing accessibility to various interventional procedures.

REPORT COVERAGE

A detailed discussion on the global Large Bore Vascular Closure Devices market, major portions of which have been touched upon. The evaluation considers market dynamics relating to driving forces like the increasing incidence of cardiovascular diseases and preferences for minimally invasive techniques, whereas the constraints would be related to the high cost of devices and stringent regulatory approvals. The companies have been profiled, with a summary of their strategies and products elaborated upon.

Key trends that shall direct the future will be bioabsorbable closure devices, improved sealing mechanisms, and automated deployment systems. Companies will simultaneously seek to expand their portfolios and enter new and emerging markets to take full advantage of accelerating demand for advanced vascular closure solution products. Joint efforts between health practitioners and manufacturers would thus advocate for the availability of these products and improved outcomes for the patients.